摘要
目的:观察左氧氟沙星300mg qd和200mg bid静点治疗老年人下呼吸道感染的疗效。方法:使用左氧氟沙星 300mg qd和200mgbid静点,治疗中、重度下呼吸道感染62例。结果:前者与后者临床有效率分别为99％和90.6％,细菌 清除率分别为85％和87.5％,总有效率分别为90％和90.9％,痊愈率分别为66.7％和59.38％,不良反应率分别6.7％ 和12.5％,经统计学处理,上述各项指标均无显著性差异(P>0.05)。结论:提示左氧氟沙星300mg静点qd的临床疗效 等同于左氧氟沙星200mg静点bid的临床疗效。
Objective: To investigate the clinical effectiveness of levefloxacin intravenously 300mg qd and 200mg bid in old patients with lower respiratory infections. Methods: Levofloxacin 300mg qd and 200mg bid were given intravenously to 62 patients with mild to severe lower respiratory infections.Results: To the levofloxacin 300mg qd and 200mg bid intravenously, the clinical effective rates were 99% vs 90.6% respectively; the bacteriological eradicative rates were 85% vs 87.5% respectively; the total effective rates were 90% vs 90.9% respectively, the cured rates were 66.7% vs 59.38% respectively; the side effect incidence rates were 6.7% vs 12.5% respectively. There was no statestic significance between the two strategies (P > 0.05). Conclusion: The clinical effectiveness was equally to the two strategies.
出处
《中国医药导刊》
2005年第2期111-112,共2页
Chinese Journal of Medicinal Guide
